New drug combo aims to tame tough blood cancer

NCT ID NCT05259839

Ongoing Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing whether adding an experimental drug called etentamig to standard multiple myeloma treatments is safe and more effective. It involves about 283 adults whose cancer has returned or stopped responding to previous therapies. Researchers will try different dose levels of etentamig combined with other approved drugs to find the best balance of safety and anti-cancer activity.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Atrium Health Levine Cancer Institute /ID# 242851

Charlotte, North Carolina, 28204, United States
CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 244145

Madrid, 28027, Spain
Calvary Mater Newcastle /ID# 243730

Waratah, New South Wales, 2298, Australia
Clinica Universidad de Navarra - Pamplona /ID# 242977

Pamplona, Navarre, 31008, Spain
Dana-Farber Cancer Institute /ID# 249529

Boston, Massachusetts, 02215, United States
Epworth Healthcare /ID# 243734

Richmond, Victoria, 3121, Australia
Fiona Stanley Hospital /ID# 244753

Murdoch, Western Australia, 6150, Australia
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 244057

Milan, 20122, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 242582

Rome, Roma, 00168, Italy
Froedtert Memorial Lutheran Hospital /ID# 242654

Milwaukee, Wisconsin, 53226-3522, United States
Hokkaido University Hospital /ID# 245966

Sapporo, Hokkaido, 060-8648, Japan
Hospital Clinic de Barcelona /ID# 242978

Barcelona, 08036, Spain
Hospital Duran i Reynals /ID# 242979

L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario 12 de Octubre /ID# 242975

Madrid, 28041, Spain
Hospital Universitario Vall de Hebron /ID# 242976

Barcelona, 08035, Spain
Hospital Universitario Virgen del Rocio /ID# 242974

Seville, 41013, Spain
Huntsman Cancer Institute /ID# 242872

Salt Lake City, Utah, 84112-5500, United States
IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 242581

Bologna, 40138, Italy
IRCCS Ospedale San Raffaele /ID# 242583

Milan, Milano, 20132, Italy
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST - IRCCS /ID# 242584

Meldola, Reggio Emilia, 47014, Italy
Kanazawa University Hospital /ID# 246812

Kanazawa, Ishikawa-ken, 920-8641, Japan
Memorial Sloan Kettering Cancer Center /ID# 244656

New York, New York, 10065-6007, United States
Moffitt Cancer Center /ID# 243437

Tampa, Florida, 33612-9416, United States
Monash Health - Monash Medical Centre /ID# 244403

Clayton, Victoria, 3168, Australia
Nagoya City University Hospital /ID# 249094

Nagoya, Aichi-ken, 467-8602, Japan
National Cancer Center Hospital East /ID# 245889

Kashiwa-shi, Chiba, 277-8577, Japan
Okayama Medical Center /ID# 245882

Okayama, Okayama-ken, 701-1192, Japan
Peter MacCallum Cancer Ctr /ID# 256880

Melbourne, Victoria, 3000, Australia
Rutenberg Cancer Center /ID# 244647

New York, New York, 10029-6030, United States
St George Hospital /ID# 243740

Kogarah, New South Wales, 2217, Australia
St Vincent's Hospital Melbourne /ID# 256879

Fitzroy Melbourne, Victoria, 3065, Australia
Sylvester Comprehensive Cancer Center /ID# 243673

Miami, Florida, 33136-1002, United States
Szpital Wojewodzki w Opolu sp. z o.o. /ID# 243954

Opole, Lower Silesian Voivodeship, 45-372, Poland
The Valley Hospital /ID# 243829

Paramus, New Jersey, 07652, United States
Universitaetsklinikum Essen /ID# 242819

Essen, 45147, Germany
Universitaetsklinikum Hamburg-Eppendorf /ID# 243141

Hamburg, 20246, Germany
Universitaetsklinikum Regensburg /ID# 242837

Regensburg, 93042, Germany
Universitaetsklinikum Tuebingen /ID# 242815

Tübingen, Baden-Wurttemberg, 72076, Germany
Universitaetsklinikum Wuerzburg /ID# 242826

Würzburg, Bavaria, 97080, Germany
University of Arkansas for Medical Sciences /ID# 243096

Little Rock, Arkansas, 72205, United States
University of Maryland, Baltimore /ID# 243679

Baltimore, Maryland, 21201, United States
University of Massachusetts - Worcester /ID# 243977

Worcester, Massachusetts, 01655, United States
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 243438

Ann Arbor, Michigan, 48109, United States
University of Texas Southwestern Medical Center /ID# 243273

Dallas, Texas, 75390-7208, United States
University of Washington /ID# 243172

Seattle, Washington, 98109, United States
Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie /ID# 243500

Lublin, Lublin Voivodeship, 20-081, Poland
Uniwersytecki Szpital Kliniczny We Wrocławiu /ID# 243246

Wroclaw, Lower Silesian Voivodeship, 50-556, Poland
Uniwersyteckie Centrum Kliniczne /ID# 243249

Gdansk, Pomeranian Voivodeship, 80-214, Poland
Yamagata University Hospital /ID# 245888

Yamagata, Yamagata, 990-9585, Japan

Conditions

Explore the condition pages connected to this study.

RELAPSED/REFRACTORY MULTIPLE MYELOMA